T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

Conditions:   Breast Cancer;   Metastatic Breast Cancer Intervention:   Drug: Trastuzumab-Deruxtecan (T-DXd) Sponsors:   MedSIR;   Daiichi Sankyo, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials